Design of the PF-ILD trial: a double-blind, randomised, placebo-controlled phase III trial of nintedanib in patients with progressive fibrosing interstitial lung disease.

Flaherty, Kevin R; Brown, Kevin K; Wells, Athol U; Clerisme-Beaty, Emmanuelle; Collard, Harold R; Cottin, Vincent; Devaraj, Anand; Inoue, Yoshikazu; Le Maulf, Florence; Richeldi, Luca; Schmidt, Hendrik; Walsh, Simon; Mezzanotte, William; Schlenker-Herceg, Rozsa

Flaherty, Kevin R; Brown, Kevin K; Wells, Athol U; Clerisme-Beaty, Emmanuelle; Collard, Harold R; Cottin, Vincent; Devaraj, Anand; Inoue, Yoshikazu; Le Maulf, Florence; Richeldi, Luca; Schmidt, Hendrik; Walsh, Simon; Mezzanotte, William; Schlenker-Herceg, Rozsa.

Afiliação

Flaherty KR; Division of Pulmonary and Critical Care Medicine, University of Michigan, Ann Arbor, Michigan, USA.
Brown KK; Department of Medicine, National Jewish Health, Denver, Colorado, USA.
Wells AU; Interstitial Lung Disease Unit, Royal Brompton Hospital, London, UK.
Clerisme-Beaty E; Boehringer Ingelheim Pharmaceuticals Inc, Ridgefield, Connecticut, USA.
Collard HR; Department of Medicine, University of California, San Francisco, San Francisco, California, USA.
Cottin V; Respiratory Diseases Department, National Reference Center for Rare Pulmonary Diseases, Respiratory Diseases Department, Louis Pradel Hospital, Claude Bernard Lyon 1 University, Lyon, France.
Devaraj A; Department of Radiology, Royal Brompton Hospital, London, UK.
Inoue Y; Clinical Research Center, National Hospital Organization, Kinki-Chuo Chest Medical Center, Osaka, Japan.
Le Maulf F; Boehringer Ingelheim France SAS Reims, Reims, France.
Richeldi L; Università Cattolica del Sacro Cuore, Fondazione Policlinico A. Gemelli, Rome, Italy.
Schmidt H; Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany.
Walsh S; Department of Radiology, King's College Hospital, London, UK.
Mezzanotte W; Boehringer Ingelheim Pharmaceuticals Inc, Ridgefield, Connecticut, USA.
Schlenker-Herceg R; Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany.

BMJ Open Respir Res ; 4(1): e000212, 2017.

Article em En | MEDLINE | ID: mdl-29018526

Palavras-chave

interstitial fibrosis; rare lung diseases

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Guideline / Qualitative_research Aspecto: Ethics Idioma: En Revista: BMJ Open Respir Res Ano de publicação: 2017 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google